EPISODE · Sep 22, 2023 · 1H 2M
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
from Hematologic Oncology Update
Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chronic lymphocytic leukemia and mantle cell lymphoma.
What this episode covers
Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chronic lymphocytic leukemia and mantle cell lymphoma.
NOW PLAYING
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
No transcript for this episode yet
Similar Episodes
May 27, 2026 ·21m
May 9, 2026 ·18m
Apr 21, 2026 ·9m
Apr 10, 2026 ·42m
Mar 28, 2026 ·24m